We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

144 hedge funds and large institutions have $528M invested in MacroGenics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,211% more call options, than puts

Call options by funds: $498K | Put options by funds: $38K

53% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 38

4.96% more ownership

Funds ownership: 93.38% → 98.34% (+5%)

8% less funds holding

Funds holding: 156 → 144 (-12)

38% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 32

43% less capital invested

Capital invested by funds: $918M → $528M (-$390M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
144
Holders Change
-12
Holders Change %
-7.69%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
58
Reduced
38
Closed
32
Calls
$498K
Puts
$38K
Net Calls
+$460K
Net Calls Change
-$160K

Top Buyers

1
AC
Armistice Capital
New York
+$25.4M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$11.9M
3
State Street
State Street
Massachusetts
+$6.98M
4
Renaissance Technologies
Renaissance Technologies
New York
+$6.47M
5
Millennium Management
Millennium Management
New York
+$5.39M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$20.2M
2
GPP
Great Point Partners
Connecticut
-$16.1M
3
BG
Bellevue Group
Switzerland
-$13.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.16M
5
GIM
Granahan Investment Management
Massachusetts
-$3.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Bellevue Group
Switzerland
$64.5M -$13.6M -1,234,948 -14%
RCM
2
RA Capital Management
Massachusetts
$53.8M – – –
BlackRock
3
BlackRock
New York
$45.5M -$308K -27,933 -0.5%
AC
4
Armistice Capital
New York
$44M +$25.4M +2,300,000 +85%
WA
5
Wasatch Advisors
Utah
$35.6M -$744K -67,362 -2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$35.5M +$950K +86,061 +2%
RI
7
RTW Investments
New York
$35M – – –
State Street
8
State Street
Massachusetts
$31.2M +$6.98M +632,054 +22%
PA
9
Perceptive Advisors
New York
$13.7M -$1.16M -105,454 -6%
Millennium Management
10
Millennium Management
New York
$13.4M +$5.39M +488,599 +47%
Assenagon Asset Management
11
Assenagon Asset Management
Luxembourg
$11M +$11.9M +1,079,273 +619%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$10.2M -$834K -75,524 -6%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$8.72M -$323K -29,222 -3%
RSCM
14
Rock Springs Capital Management
Maryland
$8.22M +$834K +75,523 +9%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$7.7M -$4.16M -376,793 -30%
Morgan Stanley
16
Morgan Stanley
New York
$5.4M +$4.05M +367,149 +149%
Northern Trust
17
Northern Trust
Illinois
$5.22M -$332K -30,042 -5%
Renaissance Technologies
18
Renaissance Technologies
New York
$5.16M +$6.47M +585,712 New
CS
19
Candriam SCA
Luxembourg
$4.56M -$333K -30,137 -6%
Charles Schwab
20
Charles Schwab
California
$4.15M +$163K +14,776 +3%
BBA
21
Baker Bros. Advisors
New York
$3.9M – – –
PA
22
Pinnacle Associates
New York
$3.56M -$163K -14,775 -4%
OM
23
Opaleye Management
Massachusetts
$3.32M -$945K -85,600 -19%
Two Sigma Investments
24
Two Sigma Investments
New York
$3.18M +$3.81M +345,046 +2,205%
Goldman Sachs
25
Goldman Sachs
New York
$2.9M -$827K -74,876 -19%
1
2 3 4 5

MGNX Hedge Fund Activity: Q1 2022 in Review

144 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2022, worth a combined $528M — down 43% from $918M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of MGNX and 20 opened new positions — a net loss of 12 holders — while 38 trimmed existing stakes and 58 added.

The largest buyer was Armistice Capital, adding an estimated $25.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $20.2M sold.

  • 144 institutional investors held MacroGenics (MGNX) as of Q1 2022, down from 156 in Q4 2021.
  • Funds reported $528M of MacroGenics stock for Q1 2022, down 43% quarter-over-quarter.
  • 20 funds opened new MacroGenics positions in Q1 2022 and 32 closed out, a net change of -12 holders.
  • The largest MacroGenics buyer in Q1 2022 was Armistice Capital, an estimated $25.4M added.
  • The largest MacroGenics seller in Q1 2022 was Point72 Asset Management, an estimated $20.2M sold.

Based on aggregated 13F filings for Q1 2022.